- call +1-201-465-4211
- email sales@mrinsights.biz
The process of developing stable cell lines often starts with transfecting selected host cells, typically CHO or HEK 293 cells with desired plasmids.
Scope of the Report:
This report studies the Cell Line Development market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cell Line Development market by product type and applications/end industries.
There is an increase in demand for the cell line development market owing to the increasing demand for monoclonal antibodies, rising vaccine production and use of innovative technologie.
The global Cell Line Development market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cell Line Development.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Corning
GE Healthcare
Lonza
Sartorius
Selexis
Sigma-Aldrich
Thermo Fisher Scientific
Wuxi Apptec
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Equipment
Media and Reagents
Market Segment by Applications, can be divided into
Bioproduction
Tissue Engineering & Regenerative Medicines
Toxicity Testing
Research
Drug Discovery
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Cell Line Development Market Overview
1.1 Product Overview and Scope of Cell Line Development
1.2 Classification of Cell Line Development by Types
1.2.1 Global Cell Line Development Revenue Comparison by Types (2017-2023)
1.2.2 Global Cell Line Development Revenue Market Share by Types in 2017
1.2.3 Equipment
1.2.4 Media and Reagents
1.3 Global Cell Line Development Market by Application
1.3.1 Global Cell Line Development Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Bioproduction
1.3.3 Tissue Engineering & Regenerative Medicines
1.3.4 Toxicity Testing
1.3.5 Research
1.3.6 Drug Discovery
1.4 Global Cell Line Development Market by Regions
1.4.1 Global Cell Line Development Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Cell Line Development Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cell Line Development Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cell Line Development Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Cell Line Development Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cell Line Development Status and Prospect (2013-2023)
1.5 Global Market Size of Cell Line Development (2013-2023)
2 Manufacturers Profiles
2.1 Corning
2.1.1 Business Overview
2.1.2 Cell Line Development Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Corning Cell Line Development Revenue, Gross Margin and Market Share (2016-2017)
2.2 GE Healthcare
2.2.1 Business Overview
2.2.2 Cell Line Development Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GE Healthcare Cell Line Development Revenue, Gross Margin and Market Share (2016-2017)
2.3 Lonza
2.3.1 Business Overview
2.3.2 Cell Line Development Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Lonza Cell Line Development Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sartorius
2.4.1 Business Overview
2.4.2 Cell Line Development Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sartorius Cell Line Development Revenue, Gross Margin and Market Share (2016-2017)
2.5 Selexis
2.5.1 Business Overview
2.5.2 Cell Line Development Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Selexis Cell Line Development Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sigma-Aldrich
2.6.1 Business Overview
2.6.2 Cell Line Development Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sigma-Aldrich Cell Line Development Revenue, Gross Margin and Market Share (2016-2017)
2.7 Thermo Fisher Scientific
2.7.1 Business Overview
2.7.2 Cell Line Development Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Thermo Fisher Scientific Cell Line Development Revenue, Gross Margin and Market Share (2016-2017)
2.8 Wuxi Apptec
2.8.1 Business Overview
2.8.2 Cell Line Development Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Wuxi Apptec Cell Line Development Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cell Line Development Market Competition, by Players
3.1 Global Cell Line Development Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Cell Line Development Players Market Share
3.2.2 Top 10 Cell Line Development Players Market Share
3.3 Market Competition Trend
4 Global Cell Line Development Market Size by Regions
4.1 Global Cell Line Development Revenue and Market Share by Regions
4.2 North America Cell Line Development Revenue and Growth Rate (2013-2018)
4.3 Europe Cell Line Development Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Cell Line Development Revenue and Growth Rate (2013-2018)
4.5 South America Cell Line Development Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Cell Line Development Revenue and Growth Rate (2013-2018)
5 North America Cell Line Development Revenue by Countries
5.1 North America Cell Line Development Revenue by Countries (2013-2018)
5.2 USA Cell Line Development Revenue and Growth Rate (2013-2018)
5.3 Canada Cell Line Development Revenue and Growth Rate (2013-2018)
5.4 Mexico Cell Line Development Revenue and Growth Rate (2013-2018)
6 Europe Cell Line Development Revenue by Countries
6.1 Europe Cell Line Development Revenue by Countries (2013-2018)
6.2 Germany Cell Line Development Revenue and Growth Rate (2013-2018)
6.3 UK Cell Line Development Revenue and Growth Rate (2013-2018)
6.4 France Cell Line Development Revenue and Growth Rate (2013-2018)
6.5 Russia Cell Line Development Revenue and Growth Rate (2013-2018)
6.6 Italy Cell Line Development Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Cell Line Development Revenue by Countries
7.1 Asia-Pacific Cell Line Development Revenue by Countries (2013-2018)
7.2 China Cell Line Development Revenue and Growth Rate (2013-2018)
7.3 Japan Cell Line Development Revenue and Growth Rate (2013-2018)
7.4 Korea Cell Line Development Revenue and Growth Rate (2013-2018)
7.5 India Cell Line Development Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Cell Line Development Revenue and Growth Rate (2013-2018)
8 South America Cell Line Development Revenue by Countries
8.1 South America Cell Line Development Revenue by Countries (2013-2018)
8.2 Brazil Cell Line Development Revenue and Growth Rate (2013-2018)
8.3 Argentina Cell Line Development Revenue and Growth Rate (2013-2018)
8.4 Colombia Cell Line Development Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Cell Line Development by Countries
9.1 Middle East and Africa Cell Line Development Revenue by Countries (2013-2018)
9.2 Saudi Arabia Cell Line Development Revenue and Growth Rate (2013-2018)
9.3 UAE Cell Line Development Revenue and Growth Rate (2013-2018)
9.4 Egypt Cell Line Development Revenue and Growth Rate (2013-2018)
9.5 Nigeria Cell Line Development Revenue and Growth Rate (2013-2018)
9.6 South Africa Cell Line Development Revenue and Growth Rate (2013-2018)
10 Global Cell Line Development Market Segment by Type
10.1 Global Cell Line Development Revenue and Market Share by Type (2013-2018)
10.2 Global Cell Line Development Market Forecast by Type (2018-2023)
10.3 Equipment Revenue Growth Rate (2013-2023)
10.4 Media and Reagents Revenue Growth Rate (2013-2023)
11 Global Cell Line Development Market Segment by Application
11.1 Global Cell Line Development Revenue Market Share by Application (2013-2018)
11.2 Cell Line Development Market Forecast by Application (2018-2023)
11.3 Bioproduction Revenue Growth (2013-2018)
11.4 Tissue Engineering & Regenerative Medicines Revenue Growth (2013-2018)
11.5 Toxicity Testing Revenue Growth (2013-2018)
11.6 Research Revenue Growth (2013-2018)
11.7 Drug Discovery Revenue Growth (2013-2018)
12 Global Cell Line Development Market Size Forecast (2018-2023)
12.1 Global Cell Line Development Market Size Forecast (2018-2023)
12.2 Global Cell Line Development Market Forecast by Regions (2018-2023)
12.3 North America Cell Line Development Revenue Market Forecast (2018-2023)
12.4 Europe Cell Line Development Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Cell Line Development Revenue Market Forecast (2018-2023)
12.6 South America Cell Line Development Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Cell Line Development Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Cell Line Development Picture
Table Product Specifications of Cell Line Development
Table Global Cell Line Development and Revenue (Million USD) Market Split by Prod
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
